GPT and fibrosis: A study demonstrated that among patients with HBeAg-positive CHB and normal ALT levels, 14.9% and 24.0% of participants exhibited significant liver inflammation and fibrosis, respectively, in contrast to 11.8% and 49.0% observed in those with HBeAg-negative CHB [19].